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Differentiation and maturation of oligodendroglial cells are postnatal processes that
involve specific morphological changes correlated with the expression of stage-specific
surface antigens and functional voltage-gated ion channels. A small fraction of
oligodendrocyte progenitor cells (OPCs) generated during development are maintained
in an immature and slowly proliferative or quiescent state in the adult central
nervous system (CNS) representing an endogenous reservoir of immature cells.
Adenosine receptors are expressed by OPCs and a key role of adenosine in
oligodendrocyte maturation has been recently recognized. As evaluated on OPC
cultures, adenosine, by stimulating A1 receptors, promotes oligodendrocyte maturation
and inhibits their proliferation; on the contrary, by stimulating A2A receptors, it
inhibits oligodendrocyte maturation. A1 and A2A receptor-mediated effects are related
to opposite modifications of outward delayed rectifying membrane K+ currents
(IK) that are involved in the regulation of oligodendrocyte differentiation. Brain
A1 and A2A receptors might represent new molecular targets for drugs useful
in demyelinating pathologies, such as multiple sclerosis (MS), stroke and brain
trauma.
Keywords: oligodendrocyte progenitor cells, adenosine A1 receptors, adenosine A2A receptors, cell differentiation,
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Oligodendrocyte Differentiation During Embryonic Development
Oligodendrocytes are neuroglial cells responsible, within the central nervous system (CNS),
for myelin sheath formation that provides an electric isolation of axons and accelerates the
transmission of electric signals. In order to become able to produce myelin, oligodendroglial
cells progress through a series of highly regulated steps of differentiation from OPCs to
mature oligodendrocytes (OLGs; Barateiro and Fernandes, 2014). OPCs are generated during
embryonic development in restricted areas, such as the subventricular zone (SVZ) and present
an amazing migratory ability that allow them to spread and populate brain and spinal cord (El
Waly et al., 2014). They are the last cells to be generated after neurons and astrocytes. Their
differentiation and maturation are postnatal processes. At the second postnatal day, rodents
(rat and mouse) present mainly pre-oligodendrocytes and myelination of the CNS starts only
at the seventh postnatal day (Dean et al., 2011). During their maturation, oligodendroglial
cells lose their ability to migrate and proliferate (Barateiro and Fernandes, 2014) and acquire
an elaborate morphology with many branched processes that wrap around axons and form
membrane sheaths of myelin, typical of mature OLGs (de Castro and Bribián, 2005; Table 1).
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TABLE 1 | Antigenic pattern typical of the different steps of
oligodendrocyte differentiation.
Oligodendrocyte Pre-oligodendrocyte: Immature Mature
progenitor cell: OPC pre-OLG OLG OLG
Nestin+ PDGFRα+ O4+ RIP+
PDGFRα+ A2B5+ RIP+ GalC+
A2B5+ NG2/AN2+ GalC+ CNP+
NG2/AN2+ GD3+ CNP+ MBP+
GD3+ PLP DM20+ PLP+
PLP DM20+ O4+ MAG+
Olig2+ CNP+
Oligodendrocyte maturation involves a sequence of distinct
phases that can be identified by the expression of stage-
specific surface antigens (Table 1) and by morphological
changes (Sommer and Schachner, 1981; Raff et al., 1983;
Goldman et al., 1984; Levi et al., 1986; Gard and Pfeiffer, 1990;
Warrington and Pfeiffer, 1992; Gallo and Armstrong, 1995;
Jung et al., 1996). These characteristics allow for a classification
into four stages of differentiation: OPC, pre-oligodendrocyte
(pre-OLG), immature oligodendrocyte and mature myelinating
oligodendrocyte (OLG; Szuchet et al., 2011; Barateiro and
Fernandes, 2014). The initial stage of maturation, as seen at
1–2 days in culture, presents a bipolar (or tripolar) morphology,
typical of OPCs (Coppi et al., 2013a). Several are the markers
of precocious maturation stages, such as platelet-derived growth
factor receptor α (PDGFRα), chondroitin sulfate proteoglycan
nerve-glial antigen 2 (NG2) or the transcription factor Olig2
(Pringle et al., 1992; Nishiyama et al., 1996; Ligon et al.,
2006). When OPCs start to differentiate in pre-OLGs, they
are characterized by emerging secondary ramifications and by
the expression of different antigens such as O4 (Sommer and
Schachner, 1981). Then they acquire the typical phenotype
of immature OLGs characterized by a complex multipolar
morphology (Back et al., 2001). At this stage, the expression
of markers typical of intermediate steps of maturation, such
as O4, persists while markers of the earlier stage such as NG2
and PDGFRα are down regulated (Yu et al., 1994). Finally,
when OLGs reach the mature myelinating stage, they acquire
highly ramified morphology and immunoreactivity for myelin
specific structural proteins such as MAG (myelin associated
glycoprotein) and MBP (myelin basic protein) (Scolding et al.,
1989; Zhang, 2001). OLGs synthesize large amounts of myelin,
giving rise to multilamellar myelin sheath that wrap and isolate
neuronal axons.
During their maturation, oligodendrocyte lineage cells display
different functional voltage-gated ion channels (Sontheimer
et al., 1989) including both inward and outward rectifying
K+ channels (Sontheimer and Kettenmann, 1988; Williamson
et al., 1997), Na+ channels (Barres et al., 1990; Berger et al.,
1992), and different subtype of Ca2+ channels (Verkhratsky
et al., 1990; Berger et al., 1992). OPCs (NG2+) show outward
membrane currents whose main component is represented
by delayed rectifying K+ currents (IK) (Gallo et al., 1996)
characterized by low time- and voltage-dependent inactivation
and by a threshold of activation at about −40 mV. On
the contrary, the transient outward current (IA), another K+
conductance typical of undifferentiated OPCs, presents a rapid
time-dependent inactivation (approximately 50 ms) and a
voltage-dependent inactivation at potentials above −40 mV
(Gallo et al., 1996). At this immature stage a subpopulation
(about 60%) of OPCs also possess an inward, tetrodotoxin-
sensitive, Na+ current (INa) characterized by a rapid time-
dependent inactivation (less than 1 ms) and by a peak of
amplitude evoked at about −10 mV (Káradóttir et al., 2008). INa
is never observed in mature oligodendroglial stages (Coppi et al.,
2013a).
During development, membrane outward K+ conductances
(both IK and IA) undergo a strong down regulation up to almost
completely disappear in mature OLGs (Sontheimer et al., 1989;
Barres et al., 1990; Gallo et al., 1996; Attali et al., 1997; Coppi
et al., 2013a).
In parallel with outward K+ current downregulation, there
is a gradual increase in the expression of inwardly rectifying
K+ currents (Kir), activated at potentials more negative than
membrane resting potential (Vm, about −70 mV). Kir currents
are the main conductance represented in mature OLGs (Knutson
et al., 1997).
Among the mentioned currents, voltage-gated K+ currents,
such as IK, IA and Kir, are involved in the regulation of
oligodendrocyte differentiation and thus of myelin formation
(Sontheimer et al., 1989; Gallo et al., 1996). In addition, the
expression of IK currents is linked to cell cycle regulation
and hence to proliferative capacity of OPCs (Chittajallu et al.,
2005) because of the following: (1) a down regulation of IK
occurs as oligodendrocyte lineage cells mature (Sontheimer
et al., 1989; Barres et al., 1990); (2) proliferative OPCs express
larger IK currents than cell cycle-arrested OPCs (Knutson
et al., 1997; Chittajallu et al., 2002); and (3) pharmacological
block of IK induced by tetra-ethyl-ammonium (TEA) in cells
belonging to the oligodendrocyte lineage is sufficient to delay
their proliferation and differentiation (Gallo et al., 1996;
Chittajallu et al., 2002). Hence, treatments aimed at modulating
these currents may affect oligodendrocyte proliferation and
differentiation.
Adult Oligodendrocyte Progenitor Cells
It has been demonstrated that a small fraction of OPCs generated
during development are maintained in an immature and slowly
proliferative or quiescent state in the adult CNS (Dawson et al.,
2003) where they are called ‘‘adult OPCs’’. Adult OPCs are
present in all brain structures where they represent the 2–9% of
the total cellular population of the CNS (Dawson et al., 2003)
thus being the largest population of proliferating cells within
the CNS (Horner et al., 2000). Adult OPCs persists stable in
the adult CNS (Rivers et al., 2008) where they represent an
endogenous reservoir of immature cells (de Castro and Bribián,
2005), constantly produced by neural stem cells located in
the SVZ (Menn et al., 2006). Current evidence suggests that
adult OPCs express the same markers (e.g., NG2 or PDGFRα)
and appear morphologically similar to their developmental
counterpart (Franklin and Ffrench-Constant, 2008).
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Very little is known about factors that control adult
oligodendrogenesis. Upon opportune physiological (e.g.,
voluntary physical exercise; Simon et al., 2011) or pathological
(e.g., injury, inflammation, demyelination) stimuli, adult OPCs
are able to react with increased proliferation and subsequent
differentiation in mature OLGs (Simon et al., 2011), thus
representing the primary source of myelinating cells in the CNS
(Nishiyama et al., 1999; Windrem et al., 2004).
Self-renewal and multipotency features of adult OPCs have
been reported. Thanks to their self-renewal features, adult OPCs
continue to proliferate throughout life span (Young et al.,
2013) and to differentiate into mature OLGs, ensuring myelin
integrity. Under specific conditions, adult OPCs give rise to
neurons, astrocytes (Nishiyama et al., 2009) and Schwann cells
(Zawadzka et al., 2010). However, multipotency of adult OPCs
is still to be confirmed since remains controversial due to some
discrepancy between in vitro and in vivo data (Crawford et al.,
2014).
Adult OPCs have been shown to contact the axonal
membrane (Butt et al., 1999) and the synaptic terminals (Ong and
Levine, 1999). This raises the question of whether adult OPCs
may be capable to impact or to react to neuronal activity (Butt
et al., 2002, 2005; Nishiyama et al., 2002). Concerning this topic
a recent study demonstrated the positive impact of neuronal
activity on myelination in the adult brain (Gibson et al., 2014).
Adenosine and Oligodendrocyte
Maturation
It is known that purines, in addition to their functions as
neurotransmitters and neuromodulators, can also act as growth
and trophic factors, thus influencing the development of
neuronal (Mishra et al., 2006; Migita et al., 2008) and glial
(Stevens and Fields, 2000; Stevens et al., 2002) cells.
All adenosine receptor subtypes (A1, A2A, A2B, A3) are
expressed on different cell types within the CNS including
oligodendrocytes, likely being able to modulate cell-to-cell
communication between neurons and glial cells (Othman et al.,
2003; Agresti et al., 2005).
The expression by oligodendrocytes of the equilibrative
nucleoside transporters ENT1 and ENT2, as well as adenosine
degrading enzymes such as adenosine deaminase and adenosine
kinase has been demonstrated (González-Fernández et al., 2014).
All adenosine receptor subtypes are also expressed by OPCs
(Stevens et al., 2002; Fredholm et al., 2011) and a key role of
adenosine in oligodendrocyte maturation has been recognized
(Burnstock et al., 2011). In particular it was demonstrated that
adenosine can affect numerous OPC processes such asmigration,
proliferation and maturation (Stevens and Fields, 2000; Stevens
et al., 2002; Coppi et al., 2013a).
Adenosine A1 Receptor-Mediated Effects on
Oligodendrogenesis
Treatment of cultured OPCs with adenosine exerts a
concentration-dependent reduction of their proliferation
in the presence of the mitogen PDGF and promotes cell
differentiation towards pre-myelinating oligodendrocytes, an
effect that is mediated by A1 receptor (Stevens et al., 2002).
A chronic adenosine treatment in co-cultures of OPCs with
dorsal root ganglion neurons also promotes myelination
as shown by the rise of MBP+ cells after 14 days (Stevens
et al., 2002). Of note, the percentage of myelinating MBP+
OLGs was lower in co-cultures treated with the adenosine
receptor antagonist, suggesting that endogenous sources
of adenosine are sufficient to promote OPC differentiation
(Stevens et al., 2002). In addition, the activation of A1 receptor
has been reported to induce OPC migration (Othman et al.,
2003).
On these basis, it was proposed that activation of A1 receptors
on OPCs by extracellular adenosine allows for the beginning of
the myelination process possibly offering new approaches for
the treatment of demyelinating diseases in the CNS, such as MS
(Stevens et al., 2002).
Such an effect, however, is different from what has been
described in neonatal rats. Neonatal rats treated with A1 receptor
agonists showed a marked reduction in white and gray matter
volume and ventriculomegaly (Turner et al., 2002) with reduced
expression of MBP similarly to what observed in neonatal
rats reared in hypoxia (Ment et al., 1998). Ventriculomegaly
was also observed in mice lacking the enzyme adenosine
deaminase which degrades adenosine (Turner et al., 2003).
Moreover, hypoxia-induced periventricular white matter injury
(PWMI, a form of brain injury sustained by preterm infants)
was prevented in mice lacking A1 receptor (Turner et al.,
2003). These data support the notion that adenosine, acting
on A1 receptor, mediates hypoxia-induced brain injury and
ventriculomegaly during early postnatal development (Turner
et al., 2003). Such effect could be attributed to the fact that
adenosine released under hypoxia and acting on A1 receptors
leads to premature differentiation and reduced proliferation of
oligodendroglia precursors. In fact, studies of OPCs and pre-
OLGs in hypoxic conditions revealed a reduced proliferation
and an accelerated maturation, as demonstrated by the increased
expression of the cell cycle regulatory proteins p27 (Kip1)
and phospho-cdc2 (Akundi and Rivkees, 2009). This series of
events would lead to a reduced number of OLGs available
for myelination, thus contributing to PWMI (see in Rivkees
and Wendler, 2011). Thus, strategies aimed at stimulating OPC
proliferation in neonatal hypoxia/ischemia may be of value to
prevent PWMI.
Adenosine A2A Receptor-Mediated Effects on
Oligodendrogenesis
The first functional characterization of adenosine A2A receptors
in OPCs has been recently reported (Coppi et al., 2013b).
It was demonstrated that the selective A2A receptor agonist
CGS21680 inhibits IK currents in cultured OPCs with an EC50
in the low nanomolar range (which is in line with values
reported in the literature: see Jarvis et al., 1989; Fredholm
et al., 2011). Furthermore, CGS21680 inhibits in vitro OPC
differentiation since it increases the percentage of NG2+
immature OPCs and reduces O4+ pre-OLGs and MAG+
mature OLGs, without affecting neither cell viability nor cell
proliferation (Coppi et al., 2013b). These effects are completely
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prevented in the presence of the selective A2A receptor antagonist
SCH58261. TEA, at concentrations that block IK but not IA
currents, mimics and occludes the effect of the A2A agonist
on membrane currents, confirming a selective modulation
by this purinergic receptor subtype of IK currents (Coppi
et al., 2013b). Similar effects mediated by A2A receptors on
outward rectifying K+ channels have already been described
in other cell types (Xu and Enyeart, 1999; Duffy et al., 2007),
with an involvement of either intracellular cAMP rise or a
direct action of the Gs protein coupled to A2A receptors
being hypothesized. Of note, we have demonstrated that the
activation of GPR17, a recently deorphanized Gi-coupled P2Y-
like receptor, which stimulates OPC differentiation (Lecca
et al., 2008; Fumagalli et al., 2011), elicits opposite effects in
comparison to the Gs coupled A2A subtype, thus increasing
the amplitude of IK currents recorded from cultured OPCs
(Coppi et al., 2013a). Increased amplitude of IK currents is
obtained also by selective stimulation of adenosine, Gi-coupled,
A1 receptors (unpublished observation mentioned in Coppi et al.
(2013b)). Taken together, these data suggest that the intracellular
signaling pathway leading to cAMP decrease in OPC cultures
are positively coupled to IK currents and cell differentiation
(Figure 1B).
In keeping with data demonstrating that the inhibition
of IK currents impairs proliferation and maturation of
cultured OPCs (Gallo et al., 1996; Attali et al., 1997; Ghiani
et al., 1999; Chittajallu et al., 2002; Vautier et al., 2004)
and blocks myelin deposition in embryonic spinal cord
(Shrager and Novakovic, 1995), it appears that A2A receptor
stimulation inhibits OPC differentiation by reducing IK
currents (Figure 1A). In line with this assumption, it has
been observed that adenosine A1 receptors, which enhances
IK currents in OPCs, exert a pro-differentiating effect in
oligodendrocyte cultures (Stevens et al., 2002; Figure 1B).
However, we cannot exclude that other intracellular pathways,
in addition to IK current block, contribute to the A2A receptor-
mediated inhibition of OPC differentiation. In OPCs, the
tyrosine kinase fibroblast growth factor receptor (FGF) is
also expressed and its activation promotes cell proliferation
and inhibits the expression of myelin components (Besnard
et al., 1989). On the contrary, the simultaneous activation
of both A2A and FGF receptors, by robust activation
of the mitogen activated protein kinase (MAPK/ERK)
pathway, brings to differentiation and neurite extension
of PC12 cells (Flajolet et al., 2008). It is likely that also in
OPCs a cross talk between the two receptors regulates cell
maturation.
Upregulation of A2A receptor has been observed in cerebral
white matter of patients with secondary progressive MS: higher
density of brain A2A receptor appeared correlated with higher
disability scale scores in MS patients (Rissanen et al., 2013).
These data were interpreted as A2A receptor upregulation
on brain cells is associated with the disease progression. In
agreement, in a mouse model of experimental autoimmune
encephalomyelitis (EAE: an animal model for MS), adenosine
A2A antagonists protected from disease development (Mills et al.,
2012), suggesting that activation of adenosine A2A receptors
on neuronal and glial cells is responsible for EAE development
in mice. Moreover in a rat model of focal brain ischemia (the
middle cerebral artery occlusion: MCAO model), adenosine A2A
receptor antagonists systemically administered after ischemia
prevented the activation of JNKmitogen activated kinase (Melani
et al., 2009) that, by activating caspase 3 and the pro-apoptotic
regulator DP5 (Yin et al., 2005), is involved in oligodendrocyte
cell death (Howe et al., 2004; Jurewicz et al., 2006). Selective A2A
adenosine antagonists also prevented the myelin disorganization
in the basal nuclei and reduced the expression of Olig2 (Melani
et al., 2009), a marker of immature OPCs, poorly expressed by
mature OLGs.
In light of these data, it can be postulated that, under
demyelinating conditions, the A2A receptor-mediated inhibition
of OPC maturation is associated with an increased damage,
since the stimulation of this receptor subtype prevents myelin
deposition.
Such a role of adenosine A2A receptor might appear in
contrast with the observation that genetic ablation of both central
and peripheral A2A receptors exacerbates brain damage and
neuroinflammation in a mouse model of EAE (Yao et al., 2012).
In fact, A2A receptors on peripheral leucocytes are known to
reduce adhesion cell factor production and neutrophil activation
(Sitkovsky et al., 2004). Thus, it is likely that genetic ablation of
adenosine A2A receptor on blood cells is crucial in exacerbating
leucocyte infiltration, neuroinflammation and brain damage in
a model of chronic inflammation such as EAE (see Pedata
et al., 2014). A regulation of neuroinflammation by adenosine
receptors might be critical in the modulation of myelin repair
mechanisms in different neurodegenerative diseases affecting
the CNS.
Effect of Caffeine on the White Matter
Injury in Hypoxic Neonatal Brain
Caffeine is widely used in neonatal medicine in order to
stimulate the respiration in premature infants. Apnea of
prematurity (AOP) is a significant clinical problem manifested
by an unstable respiratory rhythm reflecting the immaturity
of respiratory control systems. AOP typically resolves with
maturation suggesting that increased myelination of the
brainstem is required for disease remission (Mathew, 2011). This
raises the question of whether caffeine improves the myelination
and therefore the immaturity of respiratory control systems.
In hypoxia-exposed neonatal mice pups treated with caffeine,
myelination was enhanced and ventriculomegaly reduced from
postnatal days 3 through 12; furthermore, more normally
arranged myelinated axon orientation than that observed in
hypoxia was reported (Back et al., 2006). Caffeine also increased
the percentage of immature OLGs in the brain tissue (Back
et al., 2006). Further support for the notion that caffeine is
neuroprotective in development is provided by non-randomized
studies demonstrating that improved myelination is observed in
premature baboons treated with caffeine (Loeliger et al., 2006).
Caffeine is a non-selective antagonist of A1 and A2A receptors,
thus increased myelination could be ascribed to the inhibition
of one or both A1 and A2A receptor subtype. Since adenosine
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FIGURE 1 | Proposed mechanisms underlying K+ channel modulation
and differentiation of oligodendrocyte progenitor cells (OPCs: red cells)
into mature oligodendrocytes (blue cells) after purinergic receptor
activation. (A) Stimulation of the Gs coupled adenosine A2A receptor subtype
increases adenyl cyclase (AC) activity and intracellular cyclic adenosine
monophosphate (cAMP), decreases the amplitude of IK currents recorded from
cultured OPCs and inhibits OPC differentiation (Coppi et al., 2013b). (B) The
Gi-coupled adenosine A1 receptor decreases AC activity and intracellular cAMP,
increases the amplitude of IK currents recorded from cultured OPCs (Coppi
et al., 2013b) and promotes OPCs to more mature stages of differentiation
(Stevens et al., 2002). Increased amplitude of IK currents is obtained also by
selective stimulation of GPR17 (Coppi et al., 2013a), a recently deorphanized
Gi-coupled P2Y-like receptor, which decreases AC activity and intracellular
cAMP and stimulates OPC maturation (Lecca et al., 2008; Fumagalli et al.,
2011). Modulation of IK currents may be directly driven by G-protein subunit/s
or indirectly through modulation of intracellular cAMP levels.
A1 receptors are causative of hypoxia-induced brain injury and
ventriculomegaly during early postnatal development (Turner
et al., 2002, 2003), antagonism of adenosine A1 receptors is
relevant in the action mechanism of caffeine.
Conclusions
As evaluated directly on cultured OPCs, adenosine acts as a
dual modulator of OPC development since, by stimulating A1
receptors, it promotes oligodendrocyte maturation and inhibits
their proliferation (Stevens et al., 2002) and, on the contrary, by
stimulating A2A receptors, it inhibits oligodendrocytematuration
(Coppi et al., 2013b).
Most probably, the effects of adenosine on OPC maturation
are of relevance during demyelinating pathologies, such as
MS, EAE or ischemia. However, it appears that a premature
differentiation and reduced proliferation of OPCs might
compromise the process of myelination as in PWMI in preterm
infants. The outcome of stimulation of adenosine A1 and A2A
receptors on myelination depends likely on the timing of their
stimulation during the development and on the different demye-
linating pathologies.
Identification of critical regulators that inhibit
myelination/remyelination could facilitate the development
of therapeutic targets for myelin repair in CNS demyelinating
diseases. For example, the fact that in MS lesions OPCs are
present but fail to differentiate into mature OLGs (Levine
and Reynolds, 1999; Chang et al., 2000), suggests that the
remyelination process is blocked at a premyelinating stage.
Adenosine A1 and A2A receptors (to date no investigations
concerning the role of adenosine A3 or A2B receptors on
OPC maturation have been performed) represent new possible
molecular targets for drugs useful in demyelinating pathologies,
such as MS, stroke and brain trauma.
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